Regulations.gov document
Slowly Progressive, Low-Prevalence Rare Diseases With Substrate Deposition That Result…
Other · FDA-2018-D-2456 · posted Mar 16, 2020
Key facts
| Document ID | FDA-2018-D-2456-0012 |
|---|---|
| Title | Slowly Progressive, Low-Prevalence Rare Diseases With Substrate Deposition That Result From Single Enzyme Defects: Providing Evidence of Effectiveness for Replacement or Corrective Therapies; Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2018-D-2456 |
| Posted | Mar 16, 2020 |
| Comment period opens | Mar 16, 2020 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: